Navigation Links
Biotech cotton provides same yield with fewer pesticides

Arizona farmers receive the same yield/acre, use fewer chemical insecticides and maintain insect biodiversity when they plant the biotech cotton known as Bt cotton, according to new research.

The finding comes from the first large-scale study that simultaneously examined how growing Bt cotton affects yield, pesticide use and biodiversity. It's good news for the environment.

"What we see is that it's positive here in Arizona -- no doubt about it," said Yves Carrière, an associate professor of entomology at The University of Arizona in Tucson. "We've reduced pesticide use in Arizona. We've wanted to do that for 25 years."

Bt cotton has been genetically altered to produce Bt toxin, a naturally occurring insecticide that kills pink bollworm, a major pest of cotton. Bt cotton has been planted in Arizona since 1996. Now more than half of the state's 256,000 acres of cotton fields are planted with the biotech plants.

Some have suggested that, in addition to killing the target pests, insecticide-containing crops like Bt cotton would also kill beneficial and non-target arthropods.

The new study found that Bt cotton, also known as transgenic cotton, does not affect the biodiversity of insects in cotton fields.

Carrière said, "There were lots of factors that affected biodiversity in this study. Transgenics were not one of them."

He and his colleagues based their findings on a two-year study of 81 commercial cotton fields in a region of Arizona that spans about 2,500 square miles (6,600 square kilometers). Much of the field and lab work was done by Manda G. Cattaneo as part of her master's research at UA. Cattaneo is now an extension entomologist at Texas A&M University in College Station.

The multidisciplinary team will publish their research in an upcoming issue of the Proceedings of the National Academy of Sciences. A complete list of authors is at the end of this release. The Environmental Protection
'"/>

Source:University of Arizona


Page: 1 2 3

Related biology news :

1. First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology
2. MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools
3. Biotechnologys newest chemical tool
4. Biotechnologys newest chemical tool
5. Biotech cotton 8: Bugs 0
6. Open Source Biotechnology alliance for international agriculture
7. Developing uses for sugar-cane bagasse: Biotechnology applied to the paper industry
8. Bt cotton in China fails to reap profit after seven years
9. Scientists seek useful traits in wild cottons
10. MetaChip provides quick, efficient toxicity screening of potential drugs
11. NYU and MSKCC research provides model for understanding chemically induced cancer initiation
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biotech cotton provides same yield with fewer pesticides

(Date:4/17/2014)... Razzari of the nergie Matriaux Tlcommunications Research Centre ... John R. Evans Leaders Fund of the Canada ... state-of-the-art biotech and nanophotonics equipment. To this funding ... de l,Enseignement suprieur, de la Recherche, de la ... laboratories will help us develop new approaches for ...
(Date:4/17/2014)... University engineer has developed a patented technique that ... devices. The same technique could help police during ... and Kay L. Theede chair in engineering and ... his research team have created a template-based system ... trunks. The distance detection method called stand-off ...
(Date:4/17/2014)... is available in German . ... the protection money demanded of him, he can expect his ... however, as fear of the consequences is enough to make ... parasitic birds, which lay their eggs in other birds, nests. ... brood parasites take their revenge by destroying the entire nest. ...
Breaking Biology News(10 mins):New state-of-the-art biotech and nanotech equipment for INRS 2Patented research remotely detects nitrogen-rich explosives 2Fear of the cuckoo mafia 2Fear of the cuckoo mafia 3
... PHILADELPHIA -- Scientists are another step closer to ... there are factors inside tumors that can slow their ... Cancer Research , a journal of the American Association ... researcher at the division of experimental medicine at the ...
... A recent study led by researchers at Boston University School ... mortality among patients diagnosed with severe sepsis and new-onset atrial ... assistant professor of medicine at BUSM and a pulmonologist at ... study, which will be published in the Journal of the ...
... SAN FRANCISCO Combining the investigational agents REGN910 ... effects in animal models compared with either agent ... International Conference: Molecular Targets and Cancer Therapeutics, held ... findings suggest that combining REGN910 (SAR307746) and aflibercept ...
Cached Biology News:BUSM: Severe sepsis, new-onset AF associated with increased risk of hospital stroke, death 2Combination therapy shows potent tumor growth inhibition in preclinical studies 2
(Date:1/15/2014)... Freeslate, Inc ., the leading ... Lupin Limited, one of India’s top five pharmaceutical companies, ... System for high throughput solid form screening. ... a wide range of quality, affordable generic and branded ...
(Date:1/14/2014)... 14, 2014 Histogen, Inc., a regenerative ... cells grown under simulated embryonic conditions, today announced that ... Suneva Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s ... This agreement is an amendment to the existing license ...
(Date:1/14/2014)... SAN DIEGO and BETHESDA, Md. ... they are joining together with two institutes from the ... more reliable tools for bringing safer, more effective treatments ... with the National Center for Advancing Translational Sciences (NCATS) ...
(Date:1/14/2014)...   Kinaxis ®, provider of RapidResponse ®, a cloud-based ... planning ( S&OP ) service, is proud to be a ... be held at the Hilton San Diego Bayfront, January 30 ... Elisabeth Kaszas , Director of Supply Chain at Amgen, as ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... Dr. Pollard Brings the Highest Level of Clinical ... Feb. 1 Genetic,Immunity(R), a US/Hungarian clinical-stage biopharmaceutical ... patented,immunotherapeutic platform technology, announced that it has appointed,Richard ... Dr. Pollard has been a leader in HIV/AIDS ...
... N.J., Feb. 1 Amicus Therapeutics,Inc. (Nasdaq: FOLD ... Executive Officer, will present a corporate update at the ... York, NY on Thursday, February 7, 2008 at 11:40 ... The presentation will be webcast live and may be ...
... 31 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today ... of common stock at a price of $27.00,per share. ... The underwriters,have an option to purchase up to an ... is expected to close on February 6,2008, subject to ...
Cached Biology Technology:Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 2Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 3Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 2Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 3Rigel Announces Pricing of Public Offering of Common Stock 2
a1-Antitrypsin (human, alpha-1 AT)...
... vesicles are used to study co-translational ... Processing events such as signal peptide ... glycosylation can be examined by the ... vitro in the presence of these ...
... using Mo Bio luciferase assay. Mo Bio Laboratories ... will allow you to certify your products ATP-Free ... you to deliver them to your customers in ... limit is 3.5 x 10-12 /l, which will ...
... New Concept in Microarrays: Biomedical Photometrics Inc. ... GmbH (Jena, Germany) have collaborated to develop ... ArrayTube System. The DNAscope AT is ... new DNAscope AT automatically reads up to ...
Biology Products: